{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:12:30Z","timestamp":1791360750099,"version":"4.3.1"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:p>Stroke remains a significant contributor to global morbidity and mortality, with acute ischemic stroke comprising the majority of cases. Secondary stroke, the recurrent stroke, is often more severe and linked to worse functional outcomes and increased mortality. The secondary prevention of ischemic stroke is crucial for reducing the risk of recurrent events. Significant advancements have been made in secondary prevention strategies in recent years. These include the refinement of antithrombotic regimens, the use of direct oral anticoagulants in managing atrial fibrillation, and the implementation of more aggressive targets for blood pressure, lipid management, and glucose management. Furthermore, emerging therapeutic approaches, such as remote ischemic conditioning and anti-inflammatory agents such as colchicine, have shown promise in reducing stroke recurrence through nontraditional mechanisms. This review summarizes the latest advancements in the secondary prevention of ischemic stroke over the past 5 years, highlighting the key clinical trials and novel interventions. The optimization of traditional risk factor management and the emergence of novel therapeutic methods have provided more options for clinical practice. Future research should focus on identifying the optimal treatment strategies for specific patient subgroups and the clinical translation and application of new therapeutic methods.<\/jats:p>","DOI":"10.4103\/bc.bc_159_24","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T17:01:09Z","timestamp":1735318869000},"page":"283-295","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":30,"title":["Recent advances in the prevention of secondary ischemic stroke: A narrative review"],"prefix":"10.4103","volume":"10","author":[{"given":"Yue","family":"Qiao","sequence":"first","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminah I.","family":"Fayyaz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Wayne State, University School of Medicine, Detroit, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchuan","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Wayne State, University School of Medicine, Detroit, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunming","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"R1-20260423","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132021: A systematic analysis for the global burden of disease study 2021","volume":"23","year":"2024","journal-title":"Lancet Neurol"},{"key":"R2-20260423","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: A report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"R3-20260423","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","article-title":"Short-term prognosis after emergency department diagnosis of TIA","volume":"284","author":"Johnston","year":"2000","journal-title":"JAMA"},{"key":"R4-20260423","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1161\/STROKEAHA.110.602615","article-title":"Risk and cumulative risk of stroke recurrence: A systematic review and meta-analysis","volume":"42","author":"Mohan","year":"2011","journal-title":"Stroke"},{"key":"R5-20260423","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1212\/WNL.0000000000013118","article-title":"Risks of stroke recurrence and mortality after first and recurrent strokes in denmark: A nationwide registry study","volume":"98","author":"Skajaa","year":"2022","journal-title":"Neurology"},{"key":"R6-20260423","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ane.13093","article-title":"Recurrent ischemic stroke: Incidence, predictors, and impact on mortality","volume":"140","author":"Khanevski","year":"2019","journal-title":"Acta Neurol Scand"},{"key":"R7-20260423","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2471\/BLT.16.181636","article-title":"Stroke: A global response is needed","volume":"94","author":"Johnson","year":"2016","journal-title":"Bull World Health Organ"},{"key":"R8-20260423","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"R9-20260423","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/hm.hm_29_22","article-title":"Impact of Sleep on Cardiovascular Health: A Narrative Review","volume":"6","author":"Sum-Ping","year":"2022","journal-title":"Heart Mind"},{"key":"R10-20260423","first-page":"99","article-title":"Secondary prevention of ischemic stroke: Updated guidelines from AHA\/ASA","volume":"105","author":"Ford","year":"2022","journal-title":"Am Fam Physician"},{"key":"R11-20260423","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/STROKEAHA.121.035851","article-title":"Long-term secondary prevention: Management of blood pressure after a transient ischemic attack or stroke","volume":"53","author":"McGurgan","year":"2022","journal-title":"Stroke"},{"key":"R12-20260423","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1916870","article-title":"Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA","volume":"383","author":"Johnston","year":"2020","journal-title":"N Engl J Med"},{"key":"R13-20260423","doi-asserted-by":"crossref","first-page":"e209845.","DOI":"10.1212\/WNL.0000000000209845","article-title":"Duration of benefit and risk of dual antiplatelet therapy up to 72 hours after mild ischemic stroke and transient ischemic attack","volume":"103","author":"Guan","year":"2024","journal-title":"Neurology"},{"key":"R14-20260423","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","article-title":"Early versus later anticoagulation for stroke with atrial fibrillation","volume":"388","author":"Fischer","year":"2023","journal-title":"N Engl J Med"},{"key":"R15-20260423","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1161\/STROKEAHA.123.042621","article-title":"More than 50 percent reduction in LDL cholesterol in patients with target LDL <70 mg\/dL after a stroke","volume":"54","author":"Amarenco","year":"2023","journal-title":"Stroke"},{"key":"R16-20260423","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/ana.26892","article-title":"Intensive blood pressure treatment and subclinical brain infarcts: A secondary analysis of SPRINT (systolic pressure intervention trial)","volume":"95","author":"Kern","year":"2024","journal-title":"Ann Neurol"},{"key":"R17-20260423","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.2022.13123","article-title":"Effect of remote ischemic conditioning versus usual care on neurologic function in patients with acute moderate ischemic stroke: The RICAMIS randomized clinical trial","volume":"328","author":"Chen","year":"2022","journal-title":"JAMA"},{"key":"R18-20260423","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/jama.2023.16893","article-title":"Remote ischemic conditioning for acute stroke: The RESIST randomized clinical trial","volume":"330","author":"Blauenfeldt","year":"2023","journal-title":"JAMA"},{"key":"R19-20260423","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/01.str.0000437068.30550.cf","article-title":"Factors influencing the decline in stroke mortality: A statement from the American Heart Association\/American Stroke Association","volume":"45","author":"Lackland","year":"2014","journal-title":"Stroke"},{"key":"R20-20260423","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","article-title":"Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA","volume":"385","author":"Wang","year":"2021","journal-title":"N Engl J Med"},{"key":"R21-20260423","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1161\/STROKEAHA.121.034378","article-title":"Dual antiplatelet therapy using cilostazol with aspirin or clopidogrel: Subanalysis of the CSPS.com trial","volume":"52","author":"Hoshino","year":"2021","journal-title":"Stroke"},{"key":"R22-20260423","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1474-4422(23)00113-8","article-title":"Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): A randomised, double-blind, double-dummy, active control, non-inferiority trial","volume":"22","author":"Pan","year":"2023","journal-title":"Lancet Neurol"},{"key":"R23-20260423","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMoa2309137","article-title":"Dual antiplatelet treatment up to 72 hours after ischemic stroke","volume":"389","author":"Gao","year":"2023","journal-title":"N Engl J Med"},{"key":"R24-20260423","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/STROKEAHA.122.041738","article-title":"Stroke recurrence and antiplatelets in posterior versus anterior circulation minor stroke or transient ischemic attack","volume":"54","author":"Liu","year":"2023","journal-title":"Stroke"},{"key":"R25-20260423","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/STROKEAHA.120.030042","article-title":"Early apixaban use following stroke in patients with atrial fibrillation: Results of the AREST trial","volume":"52","author":"Labovitz","year":"2021","journal-title":"Stroke"},{"key":"R26-20260423","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","article-title":"Early versus delayed non-Vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): A registry-based randomized controlled noninferiority study","volume":"146","author":"Oldgren","year":"2022","journal-title":"Circulation"},{"key":"R27-20260423","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(22)01588-4","article-title":"Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): An international, randomised, double-blind, placebo-controlled, phase 2b trial","volume":"400","author":"Shoamanesh","year":"2022","journal-title":"Lancet"},{"key":"R28-20260423","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive versus standard blood pressure control on probable dementia: A randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"key":"R29-20260423","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/CIRCULATIONAHA.119.043826","article-title":"Effect of alirocumab on stroke in ODYSSEY Outcomes","volume":"140","author":"Jukema","year":"2019","journal-title":"Circulation"},{"key":"R30-20260423","doi-asserted-by":"crossref","first-page":"9.","DOI":"10.1056\/NEJMoa1910355","article-title":"A comparison of two LDL cholesterol targets after ischemic stroke","volume":"382","author":"Amarenco","year":"2020","journal-title":"N Engl J Med"},{"key":"R31-20260423","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1161\/STROKEAHA.122.039728","article-title":"Yield of dual therapy with statin and ezetimibe in the treat stroke to target trial","volume":"53","author":"Amarenco","year":"2022","journal-title":"Stroke"},{"key":"R32-20260423","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/STROKEAHA.120.033048","article-title":"Intensive versus standard treatment of hyperglycemia in acute ischemic stroke patient: A randomized clinical trial subgroups analysis","volume":"53","author":"Torbey","year":"2022","journal-title":"Stroke"},{"key":"R33-20260423","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1161\/STROKEAHA.123.044568","article-title":"Management of poststroke hyperglycemia: Results of the TEXAIS randomized clinical trial","volume":"54","author":"Bladin","year":"2023","journal-title":"Stroke"},{"key":"R34-20260423","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1474-4422(22)00335-0","article-title":"Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): A multicentre, randomised, double-blind sham-controlled trial in China","volume":"21","author":"Hou","year":"2022","journal-title":"Lancet Neurol"},{"key":"R35-20260423","doi-asserted-by":"crossref","first-page":"e079061.","DOI":"10.1136\/bmj-2023-079061","article-title":"Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): Multicentre, double blind, randomised, placebo controlled trial","volume":"385","author":"Li","year":"2024","journal-title":"BMJ"},{"key":"R36-20260423","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"R37-20260423","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N Engl J Med"},{"key":"R38-20260423","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMoa1204133","article-title":"Effects of clopidogrel added to aspirin in patients with recent lacunar stroke","volume":"367","author":"Benavente","year":"2012","journal-title":"N Engl J Med"},{"key":"R39-20260423","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"R40-20260423","first-page":"1071","article-title":"Chinese guideline for the secondary prevention of ischemic stroke and transient ischemic attack 2022","volume":"55","year":"2022","journal-title":"Chinese Journal of Neurology"},{"key":"R41-20260423","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"key":"R42-20260423","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/CIRCULATIONAHA.119.040713","article-title":"Time course for benefit and risk of clopidogrel and aspirin after acute transient ischemic attack and minor ischemic stroke","volume":"140","author":"Johnston","year":"2019","journal-title":"Circulation"},{"key":"R43-20260423","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"key":"R44-20260423","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(17)32849-0","article-title":"Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): A randomised, open-label, phase 3 superiority trial","volume":"391","author":"Bath","year":"2018","journal-title":"Lancet"},{"key":"R45-20260423","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14737175.2023.2295420","article-title":"An overview of the utility of prasugrel hydrochloride as a treatment option for ischemic stroke","volume":"24","author":"Tantry","year":"2024","journal-title":"Expert Rev Neurother"},{"key":"R46-20260423","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/10600280211073009","article-title":"Antiplatelet use in ischemic stroke","volume":"56","author":"Kamarova","year":"2022","journal-title":"Ann Pharmacother"},{"key":"R47-20260423","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/17474930221112343","article-title":"Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial","volume":"18","author":"Uchiyama","year":"2023","journal-title":"Int J Stroke"},{"key":"R48-20260423","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(03)00324-7","article-title":"Cardioembolic stroke: An update","volume":"2","author":"Ferro","year":"2003","journal-title":"Lancet Neurol"},{"key":"R49-20260423","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0140-6736(92)90873-2","article-title":"Cardiogenic embolism to the brain","volume":"339","author":"Hart","year":"1992","journal-title":"Lancet"},{"key":"R50-20260423","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","article-title":"Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: Results from a population-based study","volume":"36","author":"Marini","year":"2005","journal-title":"Stroke"},{"key":"R51-20260423","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R52-20260423","doi-asserted-by":"crossref","first-page":"e003417.","DOI":"10.1161\/CIRCIMAGING.115.003417","article-title":"Left ventricular thrombus formation after ST-segment-elevation myocardial infarction: Insights from a cardiac magnetic resonance multicenter study","volume":"8","author":"P\u00f6ss","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"R53-20260423","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"R54-20260423","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"R55-20260423","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.mcna.2016.08.005","article-title":"Adherence to antihypertensive therapy","volume":"101","author":"Peacock","year":"2017","journal-title":"Med Clin North Am"},{"key":"R56-20260423","first-page":"710","article-title":"Post-stroke antihypertensive treatment study. A preliminary result","volume":"108","year":"1995","journal-title":"Chin Med J (Engl)"},{"key":"R57-20260423","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"key":"R58-20260423","doi-asserted-by":"crossref","first-page":"i708","DOI":"10.1136\/bmj.i708","article-title":"Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST\u2013BP (prevention after stroke-- \u2013 Blood pressure) randomised controlled trial","volume":"352","author":"Mant","year":"2016","journal-title":"BMJ"},{"key":"R59-20260423","doi-asserted-by":"crossref","first-page":"e0164608.","DOI":"10.1371\/journal.pone.0164608","article-title":"Intensive versus guideline blood pressure and lipid lowering in patients with previous stroke: Main results from the pilot \u2018\u2018prevention of decline in cognition after stroke trial\u2019\u2019 (PODCAST) randomised controlled trial","volume":"12","author":"Bath","year":"2017","journal-title":"PLoS One"},{"key":"R60-20260423","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/hr.2009.139","article-title":"Blood pressure reduction for the secondary prevention of stroke: A Chinese trial and a systematic review of the literature","volume":"32","author":"Liu","year":"2009","journal-title":"Hypertens Res"},{"key":"R61-20260423","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"R62-20260423","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"key":"R63-20260423","first-page":"912","article-title":"Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: A meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988)","volume":"18","author":"Banach","year":"2022","journal-title":"Arch Med Sci"},{"key":"R64-20260423","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1093\/eurheartj\/ehz430","article-title":"Efficacy and safety of alirocumab and evolocumab: A systematic review and meta-analysis of randomized controlled trials","volume":"43","author":"Guedeney","year":"2022","journal-title":"Eur Heart J"},{"key":"R65-20260423","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/hm.HM-D-23-00028","article-title":"A narrative review on prediabetes or diabetes and atrial fibrillation: From molecular mechanisms to clinical practice","volume":"7","author":"Han","year":"2023","journal-title":"Heart Mind"},{"key":"R66-20260423","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.11.008","article-title":"Prediabetes and outcome of ischemic stroke or transient ischemic attack: A systematic review and meta-analysis","volume":"28","author":"Pan","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R67-20260423","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dc08-9026","article-title":"Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, advance, and VA diabetes trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association","volume":"32","author":"Skyler","year":"2009","journal-title":"Diabetes Care"},{"key":"R68-20260423","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.STR.0000257974.06317.49","article-title":"Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: Results from PROactive (PROspective pioglitAzone clinical trial in macrovascular events 04)","volume":"38","author":"Wilcox","year":"2007","journal-title":"Stroke"},{"key":"R69-20260423","doi-asserted-by":"crossref","first-page":"323.","DOI":"10.1186\/s12933-024-02413-w","article-title":"Impaired glucose metabolism and the risk of vascular events and mortality after ischemic stroke: A systematic review and meta-analysis","volume":"23","author":"Kaynak","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"R70-20260423","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/23969873241234238","article-title":"Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP\/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis","volume":"9","author":"Stefanou","year":"2024","journal-title":"Eur Stroke J"},{"key":"R71-20260423","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): A double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"R72-20260423","doi-asserted-by":"crossref","first-page":"m4573","DOI":"10.1136\/bmj.m4573","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"key":"R73-20260423","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.5551\/jat.30007","article-title":"Effects of pioglitazone for secondary stroke prevention in patients with impaired glucose tolerance and newly diagnosed diabetes: The J-SPIRIT study","volume":"22","author":"Tanaka","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"R74-20260423","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1161\/STROKEAHA.123.043279","article-title":"Remote ischemic conditioning: Challenges and opportunities","volume":"54","author":"Zhao","year":"2023","journal-title":"Stroke"},{"key":"R75-20260423","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/heartjnl-2020-317108","article-title":"Colchicine for acute and chronic coronary syndromes","volume":"106","author":"Imazio","year":"2020","journal-title":"Heart"},{"key":"R76-20260423","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jocn.2024.01.009","article-title":"The efficacy and safety of interleukin-1 receptor antagonist in stroke patients: A systematic review","volume":"120","author":"Kazmi","year":"2024","journal-title":"J Clin Neurosci"}],"container-title":["Brain Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_159_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:59:35Z","timestamp":1786647575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_159_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/bc.bc_159_24","relation":{},"ISSN":["2394-8108","2455-4626"],"issn-type":[{"value":"2394-8108","type":"print"},{"value":"2455-4626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2024-10-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}